Anti-Laminin 511, Human, Mouse-Mono (12D)

Product#: FNK-FDV-0026
$478.40
Availability:
Ships in 1-2 Weeks

Anti-Laminin 511, Human, Mouse-Mono (12D)


General information 

Cat. No. :FNK-FDV-0026
Size :100 ul
Format :Mouse ascites
Formulation :Ascites without any additives
Host Species and Clonality :Mouse monoclonal
Isotype and Subclass  :IgG2a
Purification :No purification
Lot Number :see vial label
Specificity :Human, other species not tested yet
Application  
  1. Western blotting under both reducing, and non-reducing conditions (1/1,000-1/10,000)
  2. Immunohistochemistry with paraffin and frozen sections
  3. Immunoprecipitaion and immunoaffinity purification
  4. ELISA
  5. NOTE: The reactivity on reducing conditions of western blotting is much weaker than on non-reducing conditions.
Storage :For short-term storage, -20oC. For long-term storage, -80oC storage is preferable. 
    Avoid repeated freeze-thaw cycles and avoid storage at 4oC

Description

Useful monoclonal antibodies for the research of cancer pathology 4 unique monoclonal antibodies against cancer-related laminin chains

Laminins are major extracellular matrix proteins containing over 15 members. Laminins are large hetero-trimers consisting of 5 alpha chains, 3 beta chains, and 3 gamma chains. Due to its structural varieties, it has been challenging to detect each laminin isoform by conventional antibodies.

Funakoshi commercializes 4 unique antibodies, originally developed by Dr. Kaoru Miyazaki, Professor Emeritus of Yokohama City University in Japan. 
Our antibodies can separately recognize specific isoforms or structures of laminin.
FDV-0023_fig1.png
Fig.1 Structure of Laminin 3A32, 3B32 and γ2pf fragment with epitopes of 3 clones (F7, BG5 and P2H).

Features
  • BG5/F7 : For laminin alpha-3 chains
    • Laminin alpha 3 chain, a major component of Laminin-332, has two splicing variants, alpha 3A and alpha 3B
    • Clone BG5 is specific antibody for alpha 3A
    • Clone F7 is the world first commercially available antibody for alpha 3B
  • P2H : For laminin gamma-2 chain
    • Laminin gamma2, an only component of Laminin-332, is a marker gene of invasive cancer tissue
    • Laminin gamma-2 chain is activated via proteolytical cleavage at N-terminal
    • N-terminal proteolytic fragment of gamma-2, called γ2pf, is highly accumulated into cytosol under malignant cancer
    • Clone P2H is the world first antibody for γ2pf
  • 12D : For laminin-511
    • There are two similar isoforms, laminin-511 and laminin-521 and it is difficult for conventional antibodies such as anti-alpha 5 chain to separate them.
    • Clone 12D specifically react with trimeric structure of laminin-511, not react with each components alpha 5, beta 1, gamma 1 and similar isoform laminin-511.
Note
Laminin 511 is used as a culture substrate for ES and iPS cells. (See our iMatrix-511 / Easy iMatrix-511).
FDV-0023_fig2.png
Fig.2 Structure of Laminin-511
 

Clone

BG5

F7

P2H

12D

Target

Laminin-α3A chain

Laminin-α3B chain

Laminin-γ2 chain N-terminal region

Laminin-511 trimer

Normal Tissue

FDV-0023_1-1.jpg

FDV-0023_1-2.jpg

FDV-0023_1-3.jpg

FDV-0023_1-4.jpg

Epitope

FDV-0023_2-1.jpg

FDV-0023_2-2.jpg

FDV-0023_2-3.jpg

FDV-0023_2-4.jpg

Cancer Tissue

FDV-0023_3-1.jpg
 

FDV-0023_3-2.jpg
 

FDV-0023_3-3.jpg
 

FDV-0023_3-4.jpg
 


Outline of four clones
 

Description

Anti-Laminin alpha 3A

Anti-Laminin alpha 3B

Anti-Laminin gamma 2 N-terminal Fragment

Anti-Laminin-511

Clone

BG5

F7

P2H

12D

Specificity

Laminin alpha 3A*1

Laminin alpha 3B

Laminin gamma 2 Domain V-NE2

Laminin-511

Host and Type

Mouse Monoclonal

Subclass

IgG2a

IgG1

IgG2a

IgG2b

Reactivity

Human

Human

Human and Mouse

Human

Form

Mouse Ascites (Unpurifed)

     

Application

ELISA, IHC, IP, WB

IHC (frozen & paraffin sections), WB

IHC (frozen), IP, WB (Non-reducing) *2

Code

FDV-0024

FDV-0023

FDV-0025

FDV-0026

Size

100 uL

Storage

-20 ℃ *3


*1 Clone BG5 only detects alpha 3A in IHC. However, this clone may react with alpha 3B in ELISA, IP and Western Blot.
*2 Clone 12D can be only used for IHC (Frozen) and under non-reducing condition for Western Blot.
*3 Non-preservative added. So these 4 clones can be degraded at 4C. We recommend -20C storage.

Data Examples

FDV-0023_fig3.png
Fig.3 IHC image of skin cancer tissue in clone BG5 and F7
Left : Clone BG5, Right : Clone F7
Both clones detected basal membrane like structure around the tumor but F7 clone also detected vascular basement membrane (arrow heads)

FDV-0023_fig4.png
Fig.4 IHC image of tissues in clone P2H
Upper images : Normal mammary gland
Lower images : Breast cancer
P2H stains basement membranes surrouding mammary glands in normal tisue, whereas in a breast cancer tissue cytoplasmic accumulation of γ2pf orits fragments is detected.

FDV-0023_fig5.png
Fig.5 IHC image of breast cancer tissue in clone 12D
A : Vascular basement membrane
B : Mammary gland basement membrane
C : Basement membrane-like structures surrounding tumor cells

FDV-0023_fig6.png 
Fig.6 Specificity of clone 12D against laminin isoforms
Seven recombinant human laminins were coated on a multi-well plate and detected by clone 12D. The data shows clone 12D specifically reacts with Laminin 511.

Reference
  1. Kariya et al., J. Biol. Chem., 279, 24774-24784 (2004) Characterization of laminin-5B (a3Bß3r2) and NH2- terminal proteolytic fragment of its a3B chain: Promotion of cellular adhesion, migration and proliferation.
  2. Kariya et al., J. Mol. Histol., 39, 435-446 (2008) Localization of laminin alpha3B chain in vascular and epithelial basement membranes of normal human tissues and its down-regulation in skin cancers.
  3. Mori et al., J. Biol. Chem., 285, 35068-35078 (2010) Laminin-3B11, a novel vascular type laminin capable of inducing prominent lamellipodial protrusions in microvascular endothelial cells.
  4. Mori et al, Camcer Sci., 102, 1095-1100 (2011) Downregulation of a newly identified laminin, laminin-3B11, in vascular basement membranes of invasive human breast cancers.
  5. Miyazaki et al., Cancer Sci., 107, 1909-1918 (2016) Highly sensitive detection of invasive lung cancer cells by novel antibody against amino-terminal domain of laminin gamma2 chain.
 
Logo_Funakoshi.png

Satisfaction
Quality Rating
Value Rating
Style Rating
X